Drugs

On March 28, 2024, the Johns Hopkins Center for Mental Health and Addiction Policy and the White House Office of National Drug Control Policy hosted a forum about new rules and federal initiatives expanding methadone access for persons who are incarcerated—part of a sweeping effort to preventfentanyl- and other opioid-related overdose deaths, reduce recidivism and increase equity post-incarceration.

On Tuesday, February 6, Jeromie Ballreich, PhD, testified before the House Ways and Means Committee, addressing the critical issue of chronic drug shortages in the United States. He highlighted the complexity of factors contributing to shortages and proposed four policy solution sets for Congress to consider.

Some people recover from COVID only to have their symptoms return a few days later. That doesn’t surprise virologists.

Following a recent high-profile death, ketamine—for decades used as a popular party drug—came under public scrutiny for its use as a treatment for everything from psychiatric illnesses to autoimmune diseases.

Public health year in review: 2023 was a mixed bag, but there is major progress worth celebrating.